Qube Research & Technologies LTD Merck & Co., Inc. Call Options Transaction History

Qube Research & Technologies LTD

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $12.3 Million - $14.3 Million	110,900 New	110,900 $12.6 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $3.87 Million - $4.21 Million	-38,600 Reduced 60.5%	25,200 $2.75 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $6.57 Million - $7.29 Million	63,800 New	63,800 $6.57 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.